沃华医药：第三季度净利润1931.86万元，同比增长63.33%

Core Viewpoint - Wohuamedicine (002107) reported a significant increase in revenue and net profit for the first three quarters of 2025, indicating strong financial performance and growth potential [1] Financial Performance - For the first three quarters, the company achieved total operating revenue of 625 million yuan, representing a year-on-year growth of 8.31% [1] - The net profit attributable to shareholders reached 63.995 million yuan, showing a substantial year-on-year increase of 179.34% [1] - In the third quarter alone, the company generated operating revenue of 199 million yuan, which is a year-on-year growth of 9.77% [1] - The net profit for the third quarter was 19.319 million yuan, reflecting a year-on-year increase of 63.33% [1]